BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 856307)

  • 21. [Effect of trypsin inhibitor of a peptide-protein nature on kallikreins from human and rabbit blood stream].
    Paskhina TS; Krinskaia AV; Zykova VP
    Biokhimiia; 1975; 40(2):302-9. PubMed ID: 1081887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; Colman RW
    Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
    [No Abstract]   [Full Text] [Related]  

  • 23. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kallikrein activation and kininogen level in rat venous and arterial blood in acute myocardial ischemia].
    Gomazkov OA; Komissarova NV; Bol'shakova LV; Shimkovich MV
    Biull Eksp Biol Med; 1973 Aug; 76(8):25-7. PubMed ID: 4544262
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation.
    Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH
    J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Amundsen E
    Haemostasis; 1978; 7(2-3):79-84. PubMed ID: 658781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of the amidase and kininogenase methods for the determination of rat urinary kallikrein.
    Berthoud VM; Corthorn JL
    J Clin Chem Clin Biochem; 1987 Sep; 25(9):595-600. PubMed ID: 3681198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kallikreinogen-kallikrein enzymatic system in human plasma. Spontaneous and after activation pool determination in healthy boys, through the use of a new kit.
    Vecchiet L; Cacchio M; Cristiano E; Del Boccio G
    Boll Soc Ital Biol Sper; 1979 Jan; 55(1):27-31. PubMed ID: 475914
    [No Abstract]   [Full Text] [Related]  

  • 30. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamics of the secretory and excretory functions of the stomach and activity of the kallikrein-kinin system following removal of the parotid glands].
    Sukhodolo VD; Vasil'ev VN
    Fiziol Zh SSSR Im I M Sechenova; 1981 Feb; 67(2):247-51. PubMed ID: 6783448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On "contact activation inhibitors" released from bovine plasma high molecular weight kininogen by plasma kallikrein (author's transl)].
    Iwanaga S; Kato H; Ham YN; Oh-Ishi S; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):575-8. PubMed ID: 567922
    [No Abstract]   [Full Text] [Related]  

  • 33. Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Lyngaas KH; Larsbraaten M; Amundsen E
    Thromb Res; 1978 Feb; 12(2):307-18. PubMed ID: 565085
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of plasmin on kallikreinogen].
    Andreenko GV; Suvorov AV
    Biokhimiia; 1976 Mar; 41(3):557-61. PubMed ID: 132197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of precipitating antibodies to pancreatic kallikrein on arginine esterase contact activation in human and rabbit blood].
    Karpitskiĭ VV; Guz SIa
    Vopr Med Khim; 1979; 25(3):242-5. PubMed ID: 452486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex dimorphism and inflammatory regulation of T-kininogen and T-kininogenase.
    Chao S; Chao L; Chao J
    Biochim Biophys Acta; 1989 Jun; 991(3):477-83. PubMed ID: 2730923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on components of the plasma kallikrein-kinin system in patients undergoing cardiopulmonary bypass.
    Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
    Adv Exp Med Biol; 1986; 198 Pt B():385-91. PubMed ID: 2433915
    [No Abstract]   [Full Text] [Related]  

  • 38. Kallikreinogen-kallikrein system during muscular work in patients with intermittent claudication: influence of tauring treatment.
    Franchi G; Fanciullacci M; Curradi C; Nuzzaci G; Monetti MG; Caternolo M
    Adv Exp Med Biol; 1976; 70(00):323-7. PubMed ID: 937138
    [No Abstract]   [Full Text] [Related]  

  • 39. Human high molecular weight kininogen. Effects of cleavage by kallikrein on protein structure and procoagulant activity.
    Schiffman S; Mannhalter C; Tyner KD
    J Biol Chem; 1980 Jul; 255(13):6433-8. PubMed ID: 6901530
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapid purification of human high molecular weight kininogen.
    Habal FM; Movat HZ
    Agents Actions; 1976 Sep; 6(5):565-8. PubMed ID: 970286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.